Cover Image
Market Research Report

Circassia Pharmaceuticals Plc - Product Pipeline Review - 2016

Published by Global Markets Direct Product code 317884
Published Content info 38 Pages
Delivery time: 1-2 business days
Price
Back to Top
Circassia Pharmaceuticals Plc - Product Pipeline Review - 2016
Published: August 24, 2016 Content info: 38 Pages
Description

Summary:

Global Markets Direct's, 'Circassia Pharmaceuticals Plc - Product Pipeline Review - 2016', provides an overview of the Circassia Pharmaceuticals Plc's pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Circassia Pharmaceuticals Plc, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope:

  • The report provides a snapshot of the pipeline therapeutic landscape of Circassia Pharmaceuticals Plc
  • The report provides overview of Circassia Pharmaceuticals Plc including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Circassia Pharmaceuticals Plc's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Circassia Pharmaceuticals Plc's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy:

  • Evaluate Circassia Pharmaceuticals Plc's strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Circassia Pharmaceuticals Plc
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Circassia Pharmaceuticals Plc's pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Table of Contents
Product Code: GMDHC08126CDB

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Circassia Pharmaceuticals Plc Snapshot
    • Circassia Pharmaceuticals Plc Overview
    • Key Information
    • Key Facts
  • Circassia Pharmaceuticals Plc - Research and Development Overview
    • Key Therapeutic Areas
  • Circassia Pharmaceuticals Plc - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Combination Treatment Modalities
  • Circassia Pharmaceuticals Plc - Pipeline Products Glance
    • Circassia Pharmaceuticals Plc - Late Stage Pipeline Products
      • Phase III Products/Combination Treatment Modalities
    • Circassia Pharmaceuticals Plc - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Circassia Pharmaceuticals Plc - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Circassia Pharmaceuticals Plc - Drug Profiles
    • Vaccine for Grass-Induced Rhinoconjunctivitis and Asthma
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • glycopyrronium bromide
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Vaccine for Asthma and Ragweed-Induced Rhinoconjunctivitis
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Vaccine for Birch Pollen Allergy
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Vaccine for House Dust Mite Induced Allergic Rhinoconjunctivitis
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • (fluticasone propionate + glycopyrronium bromide + salmeterol xinafoate)
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Vaccine for Japanese Cedar Pollen Allergy
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • (Inhaled Corticosteroid + Long-acting Muscarinic Antagonist)
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • (Long Acting Beta-2 Agonist + Long Acting Muscarinic Receptor Antagonist)
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Vaccine for Alternaria Allergy
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Circassia Pharmaceuticals Plc - Pipeline Analysis
    • Circassia Pharmaceuticals Plc - Pipeline Products by Target
    • Circassia Pharmaceuticals Plc - Pipeline Products by Route of Administration
    • Circassia Pharmaceuticals Plc - Pipeline Products by Molecule Type
    • Circassia Pharmaceuticals Plc - Pipeline Products by Mechanism of Action
  • Circassia Pharmaceuticals Plc - Recent Pipeline Updates
  • Circassia Pharmaceuticals Plc - Dormant Projects
  • Circassia Pharmaceuticals Plc - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Circassia Pharmaceuticals Plc, Key Information
  • Circassia Pharmaceuticals Plc, Key Facts
  • Circassia Pharmaceuticals Plc - Pipeline by Indication, 2016
  • Circassia Pharmaceuticals Plc - Pipeline by Stage of Development, 2016
  • Circassia Pharmaceuticals Plc - Monotherapy Products in Pipeline, 2016
  • Circassia Pharmaceuticals Plc - Combination Treatment Modalities in Pipeline, 2016
  • Circassia Pharmaceuticals Plc - Phase III, 2016
  • Circassia Pharmaceuticals Plc - Phase II, 2016
  • Circassia Pharmaceuticals Plc - Phase I, 2016
  • Circassia Pharmaceuticals Plc - Preclinical, 2016
  • Circassia Pharmaceuticals Plc - Pipeline by Target, 2016
  • Circassia Pharmaceuticals Plc - Pipeline by Route of Administration, 2016
  • Circassia Pharmaceuticals Plc - Pipeline by Molecule Type, 2016
  • Circassia Pharmaceuticals Plc - Pipeline Products by Mechanism of Action, 2016
  • Circassia Pharmaceuticals Plc - Recent Pipeline Updates, 2016
  • Circassia Pharmaceuticals Plc - Dormant Developmental Projects,2016
  • Circassia Pharmaceuticals Plc, Subsidiaries

List of Figures

  • Circassia Pharmaceuticals Plc - Pipeline by Top 10 Indication, 2016
  • Circassia Pharmaceuticals Plc - Pipeline by Stage of Development, 2016
  • Circassia Pharmaceuticals Plc - Monotherapy Products in Pipeline, 2016
  • Circassia Pharmaceuticals Plc - Combination Treatment Modalities in Pipeline, 2016
  • Circassia Pharmaceuticals Plc - Pipeline by Target, 2016
  • Circassia Pharmaceuticals Plc - Pipeline by Route of Administration, 2016
  • Circassia Pharmaceuticals Plc - Pipeline by Molecule Type, 2016
  • Circassia Pharmaceuticals Plc - Pipeline Products by Mechanism of Action, 2016
Back to Top